CXCR2 and cancer: Inhibition of CXCR2 by SB225002 attenuated the upregulation of SAA1 by LECs co-cultured with LC cells, suggesting that LEC-derived chemokines may reciprocally activate SAA1 expression in cancer cells via CXCR2 (Figure 5C).